Physician profile
Robert House
NPI 1184116964
$4,578.13
in general payments reported to CMS, 2019-2025
23 companies · $1,011 in 2025
The $1,011 reported for 2025 was more than what 77% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $813 · 2020: $157 · 2021: $409 · 2022: $877 · 2023: $440 · 2024: $872 · 2025: $1,011.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,125 · Education: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,124.95 |
| Education | $197.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,304.01 | 2019-2025 | Clareon, Unity, Rocklatan |
| Abbvie INC. | $411.29 | 2022-2025 | |
| Mallinckrodt Hospital Products INC. | $346.36 | 2020-2024 | Acthar |
| Allergan, INC. | $292.16 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $284.56 | 2022-2025 | Miebo, Xiidra, Lotemax Sm |
| New World Medical,INC. | $260.54 | 2023-2025 | Ahmed Glaucoma Valve, Streamline, Clearpath |
| Glaukos Corporation | $242.69 | 2021-2025 | Idosetr |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $218.67 | 2019-2021 | |
| Sight Sciences, INC. | $196.28 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Novartis Pharmaceuticals Corporation | $184.99 | 2019-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $170.72 | 2022-2025 | Catalys System, Tecnis Iol |
| Alimera Sciences, INC. | $139.37 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $103.66 | 2024-2025 | Xdemvy |
| Rayner Intraocular Lenses Limited | $102.43 | 2023-2025 | Omidria, Rayone Aspheric, Rayone Spheric |
| Sun Pharmaceutical Industries INC. | $78.85 | 2023-2025 | Cequa |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $48.54 | 2023-2024 | Iyuzeh |
| Rxsight INC | $47.47 | 2024-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Oyster Point Pharma, INC. | $36.42 | 2022-2024 | Ryzumvi, Tyrvaya |
| Ocular Therapeutix, INC. | $29.57 | 2022-2023 | Dextenza |
| Ge Healthcare | $25.66 | 2021 | |
| Biotissue Holdings INC. | $20.83 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.92 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $14.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert House listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.